Further Definition of the D1 Dopamine Receptor Pharmacophore: Synthesis of trans-6,6a,7,8,9,13b-Hexahydro-5H-benzo[d]naphth[2,1-b]azepines as Rigid Analogues of β-Phenyldopamine
Val Watts
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Conformational Analysis of D1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping
Val Watts
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Structural Factors that Distinguish Dopamine D1 and D2 Agonists
Emile Bellott
Journal of Molecular Modeling, 1995
View PDFchevron_right
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
Ferran Sanz
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol
R. Chipkin, Donald Hou
Journal of medicinal chemistry, 1989
View PDFchevron_right
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626
Robert Mach, Jinbin Xu
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Synthesis, dopamine D 2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1 H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1 H-benzimidazole and their analogs
Goran Roglic
European Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Optically active benzamides as predictive tools for mapping the dopamine D2 receptor
André Mann
European Journal of Pharmacology: Molecular Pharmacology, 1990
View PDFchevron_right
Synthesis, in silico, and in vitro studies of novel dopamine D2and D3receptor ligands
Katarina Nikolic
Archiv Der Pharmazie, 2021
View PDFchevron_right
Dopaminergic Benzo[a]phenanthridines: Resolution and Pharmacological Evaluation of the Enantiomers of Dihydrexidine, the Full Efficacy D1 Dopamine Receptor Agonist
Richard Mailman
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
A pharmacophore model for dopamine D4 receptor antagonists
Klaus Gundertofte
2000
View PDFchevron_right
Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies
Shu-Yuan Cheng
Biochemical Pharmacology, 2011
View PDFchevron_right
DOPAMINE D 2 RECEPTOR ANTAGONIST ACTIVITY AND MOLECULAR MODELING OF CERTAIN NEW CYCLOHEXANE DERIVED ARYLCARBOXAMIDES STRUCTURALLY RELATED TO METOCLOPRAMIDE
Aida El-Azzouny
Digest Journal of Nanomaterials and Biostructures
View PDFchevron_right
(.+-.)-(Aminoalkyl)benzazepine Analogs: Novel Dopamine D1 Receptor Antagonists
Jeffrey Witkin
Journal of Medicinal Chemistry, 1995
View PDFchevron_right
trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists
Yu-Gui Gu
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
(±)-3-[4‘-( N , N -Dimethylamino)cinnamyl]benzazepine Analogs: Novel Dopamine D 1 Receptor Antagonists †
Jeffrey Witkin
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Synthesis, in silico, and in vitro studies of novel dopamine D 2 and D 3 receptor ligands
Holger Stark
Archiv der Pharmazie, 2021
View PDFchevron_right
Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors
Curtiss Durand
Molecular Pharmacology, 2005
View PDFchevron_right
ChemInform Abstract: Heterocyclic Congeners of PD 128,907 with a Partially Hydrogenated Benzomorpholine Moiety as Potential Dopamine D3-Receptor Ligands
Holger Stark
Cheminform, 2010
View PDFchevron_right
Dopamine D4 Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy
Russell Burkhardt
Journal of Medicinal Chemistry, 2019
View PDFchevron_right
Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain
Harel Weinstein
Molecular Pharmacology, 2004
View PDFchevron_right
DOPAMINE D2 RECEPTOR ANTAGONIST ACTIVITY AND MOLECULAR MODELING OF CERTAIN NEW CYCLOHEXANE DERIVED ARYLCARBOXAMIDES …
Abdel-Sattar S. Hamad Elgazwy
chalcogen.ro
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands. 10: 1 SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D 1 , D 2L , and D 5 Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D 1 /D 5 Selective Antagonist
Sherif Rostom, Matthias Kassack, Hussein El-subbagh
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Azaindole derivatives with high affinity for the dopamine D4 receptor: Synthesis, ligand binding studies and comparison of molecular electrostatic potential maps
Harald Hübner
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands
Boeun Lee
Molecules, 2021
View PDFchevron_right
A Density Functional Study of the Relationships between Electronic Structure and Dopamine D2 receptor binding affinity of a series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines
Juan Sebastián Gómez-Jeria
Research Journal of Pharmaceutical, Biological and Chemical Sciences
View PDFchevron_right
Investigation of key interactions between the second extracellular loop of dopamine D2 receptor and several hydroxy-N-{[2-(4-phenyl-piperaziny-1-yl)ethyl]phenyl}-nicotinamides
Đurđica Ignjatović
Journal of the Serbian Chemical Society, 2014
View PDFchevron_right